Optibiotix Health Share Discussion Threads

[pol pot] 01/7/2022 12:14

As part of the OptiBiotix Share Option Plan, options over 500,000 new ordinary shares have been granted to René Kamminga (the "Options"). The Options are exercisable within 10 years at an exercise price of 2p per share, which will be subject to a combination of performance and time-based vesting criteria.

[kreature] 01/7/2022 09:06

10 pips away from 10p now
How did Elton get it so wrong

[vlad the impaler] 30/6/2022 21:12

Revenues of £1.5 million .. lol. Industry standard

.......

Anyway nice to see such a finance arrangement

Won't be long now, somebody else's turn

[vlad the impaler] 30/6/2022 21:10

Shield had a transformational 2021, successfully launching Accrufer® in the US, with strong growth in revenue and demand, and achieving a solid start to the financial year. The Company executed 100% growth in prescriptions for the first months of 2022 whilst focusing on the Company's three main priorities: increasing awareness of Accrufer®, generating clinical experience and expanding payor coverage.

100% increase in total Accrufer® prescriptions

Greg Madison, CEO of Shield Therapeutics, stated: "I am extremely proud of the team here at Shield and the incredible work they have done.

Are these guys all chewing the same grass ?

[vlad the impaler] 30/6/2022 21:08

STX seems to be finding home now that 4D pharma has

[vlad the impaler] 30/6/2022 15:45

Not sure why it's trading 450% above fair value. APPL never even did that

[vlad the impaler] 30/6/2022 14:46

Today seems more real